Related Experiment Video
Updated: Jan 17, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
Published on: February 28, 2025
Chemical Proteomics-Guided Discovery of Covalent Ligands for Cancer Proteins
Xiaoyu Zhang1, Benjamin F Cravatt2
1Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.
Abstract:
Advances in genome sequencing and editing technologies have enriched our understanding of the biochemical pathways that drive tumorigenesis. Translating this knowledge into new medicines for cancer treatment, however, remains challenging, and many oncogenic proteins have proven recalcitrant to conventional approaches for chemical probe and drug discovery. Here, we discuss how innovations in chemical proteomics and covalent chemistry are being integrated to identify and advance first-in-class small molecules that target cancer-relevant proteins. Mechanistic studies have revealed that covalent compounds perturb protein functions in cancer cells in diverse ways that include the remodeling of protein-protein and protein-RNA complexes, as well as through alterations in post-translational modification. We speculate on the attributes of chemical proteomics and covalent chemistry that have enabled targeting of previously inaccessible cancer-relevant pathways and consider technical challenges that remain to be addressed in order to fully realize the druggability of the cancer proteome.
Insights
Innovations in chemical proteomics and covalent chemistry are enabling the development of novel small molecule drugs targeting previously undruggable cancer proteins. These approaches offer new ways to perturb protein functions and advance cancer treatment.
Area of Science:
- Biochemistry
- Chemical Biology
- Oncology
Background:
- Genomic advances have improved understanding of cancer pathways.
- Targeting oncogenic proteins with conventional drugs remains difficult.
Purpose of the Study:
- To discuss the integration of chemical proteomics and covalent chemistry for cancer drug discovery.
- To explore how these methods identify and advance novel small molecule cancer therapeutics.
Main Methods:
- Utilizing innovations in chemical proteomics.
- Applying principles of covalent chemistry.
- Conducting mechanistic studies on small molecule interactions with proteins.
Main Results:
- Covalent compounds were identified as first-in-class small molecules targeting cancer proteins.
- Mechanistic studies revealed diverse perturbations of protein functions by covalent compounds.
- These perturbations include remodeling of protein-protein and protein-RNA complexes and altered post-translational modifications.
Conclusions:
- Chemical proteomics and covalent chemistry enable targeting of previously inaccessible cancer pathways.
- Further technical development is needed to fully realize the druggability of the cancer proteome.
More Related Videos
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Targeted Cancer Therapies
There are several types of targeted therapies against...